絞り込み

18382

広告

「叡王戦」異例の第9局で豊島竜王勝利「二冠」に返り咲き

将棋の八大タイトルの1つ「叡王戦」の七番勝負は、2回の引き分けがあったことから「第9局」までもつれ込む異例の展開となった結果、挑戦者の豊島将之竜王(30)がタイ...

  1. [企業] RocheがInflazome...
  2. 20世紀まで残った決闘 中心地だったフラ...
  3. 森と湖が広がる北の原野に環境破壊の恐れ、...
  4. 検証プラス・新型コロナ:遅い政策、消えた...

ニュース一覧

Design and synthesis of tetrahydropyridopyrimidine derivatives as dual GPR119 and DPP-4 modulators.

著者 Fang Y , Zhang S , Wu W , Liu Y , Yang J , Li Y , Li M , Dong H , Jin Y , Liu R , Yang Z
Bioorg Chem.2019 Oct 22 ; ():103390.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (50view , 0users)

Full Text Sources

Based on the approach of merged pharmacophores of GPR119 agonists and DPP-4 inhibitors, a series of tetrahydropyridopyrimidine compounds were designed as dual GPR119 and DPP-4 modulators with hypoglycemic activity. Seven fragments extracted from DPP-4 inhibitors were hybridized with the scaffold of tetrahydropyridopyrimidine. Among them, compound 51 displayed most potent GPR119 agonistic activity (EC = 8.7 nM) and good inhibition rate of 74.5% against DPP-4 at 10 μM. Furthermore, the blood glucose AUC of 51 was reduced to 19.5% in the oral glucose tolerance test (oGTT) at the dose of 30 mg/kg in C57BL/6N mice, which was more potent than that of vildagliptin (16.4%) at the same dose. The docking study of compound 51 with DPP-4 indicated GPR119 agonists could inhibit DPP-4 to serve as dual GPR119 and DPP-4 modulators.
PMID: 31662212 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード